Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA MI-2 CTRPv2 pan-cancer AAC 0.047 0.4
mRNA L-685458 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA pifithrin-alpha CTRPv2 pan-cancer AAC -0.033 0.4
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.032 0.4
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.032 0.4
Download CSV